[1] [1] F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, A. Jemal, “Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,” CA: A Cancer J. Clinicians 68, 394–424 (2018).

[2] [2] A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, D. Forman, “Global cancer statistics,” CA: A Cancer J. Clinicians 61, 69–90 (2011).

[3] [3] L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, A. Jemal, “Global cancer statistics, 2012,” CA: A Cancer J. Clinicians 65, 87–108 (2015).

[4] [4] H. H. Hartgrink, E. P. Jansen, N. C. van Grieken, C. J. van de Velde, “Gastric cancer,” Lancet 374, 477–490 (2009).

[5] [5] B. Nokes, M. Apel, C. Jones, G. Brown, J. E. Lang, “Aminolevulinic acid (ALA): photodynamic detection and potential therapeutic applications,” J. Surg. Res. 181, 262–271 (2013).

[6] [6] M. Nakamura, A. Goto, A. Nishikawa, H. Shibata, “Preliminary study of photodynamic diagnosis using 5-aminolevulinic acid in gastric and colorectal tumors,” World J. Gastroenterol. 21, 6706–6712 (2015).

[7] [7] M. Ishizuka, F. Abe, Y. Sano, K. Takahashi, K. Inoue, M. Nakajima, T. Kohda, N. Komatsu, S. Ogura, T. Tanaka, “Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy,” Int. Immunopharmacol. 11, 358–365 (2011).

[8] [8] H. L. Lee, C. S. Eun, O. Y. Lee, D. S. Han, B. C. Yoon, H. S. Choi, J. S. Hahm, D. H. Koh, “When do we miss synchronous gastric neoplasms with endoscopy?” Gastrointest. Endosc. 71, 1159–1165 (2010).

[9] [9] A. N. Pavlov, O. V. Semyachkina-Glushkovskaya, O. N. Pavlova, O. A. Bibikova, J. Kurths, “Wavelet-analysis of gastric microcirculation in rats with ulcer bleedings,” Eur. Phys. J. Special Topics 222(10), 2705–2712 (2013).

[10] [10] O. V. Semyachkina-Glushkovskaya, I. A. Frolov, I. A. Semyachkin-Glushkovskii, S. V. Kapralov, T. G. Anishchenko, S. S. Sindeev, V. V. Tuchin, “Method for prediction of recurrent hemorrhages from acute gastroduodenal ulcers,” Patent RU 2469330 (2011), http://www.freepatent.ru/images/patents/146/246 9330/patent-2469330.pdf

[11] [11] A. R. Poh, R. J. J. ODonoghue, M. Ernst, T. L. Putoczki, “Mouse models for gastric cancer: Matching models to biological questions,” J. Gastroenterol. Hepatol. 31, 1257–1272 (2016).

[12] [12] K. Sintara, D. Thong-Ngam, “Gastric cancer: The experimental models,” Thai. J. Physiol. Sci. 21(1), 31–38 (2008).

[13] [13] T. Yamachika, H. Nakanishi, K. Inada, T. Tsukamoto, N. Shimizu, K. Kobayashi, S. Fukushima, M. Tatematsu, “N-methyl-N-nitrosourea concentration-dependent, rather than total intake-dependent, induction of adenocarcinomas in the glandular stomach of BALB/c mice,” Jpn. J. Cancer Res. 89(4), 385–391 (1998).

[14] [14] X. Cai, J. Carlson, C. Stoicov, H. Li, T. Wang, J. Houghton, “Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice,” Gastroenterol. 128, 1937–1952 (2005).

[15] [15] M. O. Gut, S. Parkkila, Z. Vernerová, E. Rohde, J. Závada, M. Hocker, J. Pastorek, T. Karttunen, A. Gibadulinová, Z. Závadová, K. P. Knobeloch, B. Wiedenmann, J. Svoboda, I. Horak, S. Pastoreková, “Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9,” Gastroenterol. 123, 1889–1903 (2002).

[16] [16] K. C. Ray, K. M. Bell, J. Yan, G. Gu, C. H. Chung, M. K. Washington, A. L. Means, “Epithelial tissues have varying degrees of susceptibility to Kras G12D -initiated tumorigenesis in a mouse model,” PLoS One 6, e16786 (2011).

[17] [17] M. Tatematsu, M. Yamamoto, H. Iwata, H. Fukami, H. Yuasa, N. Tezuka, T. Masui, H. Nakanishi, “Induction of glandular stomach cancers in C3H mice treated with N-methyl-N-nitrosourea in the drinking water,” Jpn. J. Cancer Res. 84, 1258–1264 (1993).

[18] [18] N. Okhotnikova, S. Dadvany, M. Kuszin, S. Kharnas, V. Zavodnov, O. Sklyanskaya, V. Loschenov, A. Volkova, V. Agafonov, “Application of 5-ALA for differential diagnostics of stomach diseases,” Proc. SPIE 4156, 256–271 (2001).

[19] [19] M. Costa, A. L. Goldberger, C.-K. Peng, “Multiscale entropy analysis of biological signals,” Phys. Rev. E 71, 021906 (2005).

[20] [20] M. Costa, A. L. Goldberger, C.-K. Peng, “Multiscale entropy analysis of physiologic time series,” Phys. Rev. Lett. 89, 062102 (2002).

[21] [21] A. L. Goldberger, L. A. Nunes Amaral, L. Glass, J. M. Hausdorff, P. Ch. Ivanov, R. G. Mark, J. E. Mietus, G. B. Moody, C.-K. Peng, H. E. Stanley, “PhysioBank, PhysioToolkit, and PhysioNet: Components of a new research resource for complex physiologic signals,” Circulation 101(23), e215–e220 (2000) [Circulation Electronic Pages; http://circ.ahajournals.org/cgi/content/full/101/23/e215].

[22] [22] C.-K. Peng, S. V. Buldyrev, S. Havlin, M. Simons, H. E. Stanley, A. L. Goldberger, “Mosaic organization of DNA nucleotides,” Phys. Rev. E 49, 1685–1689 (1994).

[23] [23] R. Schoental, “Carcinogenic activity of N-methyl-N-nitroso-N′-nitroguanidine,” Nature 209, 726–727 (1966).

[24] [24] T. Sugimura, S. Fujimura, “Tumour production in glandular stomach of rat by N-methyl-N’-nitro-N-nitrosoguanidine,” Nature 216, 943–944 (1967).

[25] [25] A. Khorovodov, I. Agranovich, N. Shushunova, N. Navolokin, A. Telegin, A. Shnitenkova, M. Sagatova, I. Trishkina, M. Ulanova, E. Borisova, O. Semyachkina-Glushkovskay, “The role of stress and nitrosamines in the development of gastric cancer: A new model of adenocarcinoma formation with metastases in rats,” United Euro. Gastroenterol. J. 5(5S), A 369 (2017).

[26] [26] M. Moreno-Smith, S. K. Lutgendorf, A. K. Sood, “Impact of stress on cancer metastasis,” Future Oncol. 6(12), 1863–1881 (2010).

[27] [27] D. Spiegel, J. Giese-Davis, “Depression and cancer: Mechanisms and disease progression,” Biol. Psychiatry 54(1), 269–282 (2003).

[28] [28] Y. L. Michael, N. E. Carlson, R. T. Chlebowski, M. Aickin, K. S. Weihs, J. K. Ockene, D. J. Bowen, C. Ritenbaugh, “Influence of stressors on breast cancer incidence in the Women’s Health Initiative,” Health Psychol. 28(2), 137–146 (2009).

[29] [29] D. E. Shuker, H. Bartsch, “DNA adducts of nitrosamines,” IARC Sci. Pub. 125, 73–89 (1994).

[30] [30] P. Jakszyn, C. A. Gonzalez, “Nitrosamine and related food intake and gastric and oesophageal cancer risk: A systematic review of the epidemiological evidence,” World J. Gastroenterol. 12(27), 4296–4303 (2006).

[31] [31] K. Zali, M. Rezaei-Tavirani, M. Azodi, “Gastric cancer: Prevention, risk factors and treatment,” Gastroenterol. Hepatol. Bed. Bench. 4(4), 175–185 (2011).

[32] [32] J. Powell, C. C. McConkey, “Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites,” Br. J. Cancer. 62, 440–443 (1990).

[33] [33] A. H. Merry, L. J. Schouten, R. A. Goldbohm, P. A. van den Brandt, “Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: A prospective cohort study,” Gut 56, 1503–1511 (2007).

[34] [34] M. Lindblad, L. A. Rodriguez, J. Lagergren, “Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study,” Cancer Causes Control 16, 285–294 (2005).

[35] [35] G. E. Moore, W. T. Peyton, “The clinical use of fluorescein in neurosurgery; the localization of brain tumors,” J. Neurosurg. 5, 392–398 (1948).

[36] [36] T. Namikawa, K. Inoue, S. Uemura, M. Shiga, H. Maeda, H. Kitagawa, H. Fukuhara, M. Kobayashi, T. Shuin, K. Hanazaki, “Photodynamic diagnosis using 5-aminolevulinic acid during gastrectomy for gastric cancer,” J. Surg. Oncol. 109, 213–217 (2014).

[37] [37] T. Nakamura, T. Oinuma, H. Yamagishi, H. Masuyama, A. Terano, “Evaluation of a novel high-resolution magnifying videoendoscope that is capable of photodynamic diagnosis and therapy for gastric cancer,” Photodiagnosis Photodyn. Ther. 12, 115–122 (2015).

[38] [38] N. Haj-Hosseini, J. Richter, S. Andersson-Engels, K. Wardell, “Photobleaching behavior of protoporphyrin IX during 5-aminolevulinic acid marked glioblastoma detection,” Proc. SPIE 7161, 716131 (2009).

[39] [39] E. Borisova, B. Vladimirov, R. Ivanova, L. Avramov, “Light-induced fluorescence techniques for gastrointestinal tumour detection, ” in New Techniques in Gastrointestinal Endoscopy, Oliviu PascuAndrada Seicean (Ed.), InTech, Chap. 14, pp. 231–252 (2011).

[40] [40] S. Kiyotoki, J. Nishikawa, T. Okamoto, K. Hamabe, M. Saito, A. Goto, Y. Fujita, Y. Hamamoto, Y. Takeuchi, S. Satori, I. Sakaida, “New method for detection of gastric cancer by hyperspectral imaging: A pilot study,” J. Biomed. Opt. 18, 26010 (2013).

[41] [41] W. D. Tope, E. V. Ross, N. Kollias, A. Martin, R. Gillies, R. R. Anderson, “Protoporphyrin IX fluorescence induced in basal cell carcinoma by oral delta-aminolevulinic acid,” Photochem. Photobiol. 67, 249–255 (1998).

[42] [42] B. Mayinger, S. Neidhardt, H. Reh, P. Martus, E. G. Hahn, “Fluorescence induced with 5-aminolevulinic acid for the endoscopic detection and follow-up of esophageal lesions,” Gastrointest. Endosc. 54, 572–578 (2001).